Abstract

The phenomenon known as a "cytokine storm" is characterised by a surge in the production of a large number of cytokines, which are known to induce lung tissue fibrosis as well as damage that persists over time. This condition may be recognised by the fact that there is an increase in the overall quantity of cytokines that are released into the circulation. It is not quite clear whether these shifts came about as a result of the immunomodulation that the medicine delivered or whether they were the result of the illness process itself. In addition, more research is required to shed light on the probable relationship that exists between these inflammatory markers and the progression and severity of COVID-19. This connection has not yet been established. The purpose of this study was to describe any changes that may have occurred in the inflammatory markers of symptomatic COVID-19 patients and to establish a connection between these changes and the severity of the disease and its prognosis.

Description